SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-18-312414
Filing Date
2018-10-30
Accepted
2018-10-30 17:23:24
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B3 d626457d424b3.htm 424B3 2496652
2 GRAPHIC g626457g06h20.jpg GRAPHIC 22804
3 GRAPHIC g626457g08q02.jpg GRAPHIC 32315
4 GRAPHIC g626457g14t49.jpg GRAPHIC 18240
5 GRAPHIC g626457g15s09.jpg GRAPHIC 35777
6 GRAPHIC g626457g29l79.jpg GRAPHIC 18302
7 GRAPHIC g626457g36x21.jpg GRAPHIC 34695
8 GRAPHIC g626457g38j35.jpg GRAPHIC 23442
9 GRAPHIC g626457g48p04.jpg GRAPHIC 30554
10 GRAPHIC g626457g58e24.jpg GRAPHIC 36098
11 GRAPHIC g626457g78j82.jpg GRAPHIC 31169
12 GRAPHIC g626457g78l46.jpg GRAPHIC 32009
13 GRAPHIC g626457g81g05.jpg GRAPHIC 42610
14 GRAPHIC g626457g96u74.jpg GRAPHIC 18404
15 GRAPHIC g626457g97c19.jpg GRAPHIC 21521
  Complete submission text file 0001193125-18-312414.txt   3047851
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-227622 | Film No.: 181147941
SIC: 2834 Pharmaceutical Preparations